Research Scientist II
Confirmed live in the last 24 hours
Tempus

1,001-5,000 employees

AI-driven precision medicine through clinical and molecular data analysis
Company Overview
Tempus Labs, Inc. is a leader in precision medicine, leveraging artificial intelligence to analyze vast clinical and molecular data, enabling physicians to deliver personalized, data-driven care. The company's advanced machine learning platform and unique solution sets facilitate the discovery, development, and delivery of optimized therapeutic options for patients. With a focus on extensive molecular profiling, Tempus has developed a robust pan-cancer tumor organoid platform and validated a liquid biopsy assay, demonstrating their commitment to transforming personalized patient care and their position at the forefront of the healthcare industry.
AI & Machine Learning
Data & Analytics

Company Stage

Series G

Total Funding

$1.3B

Founded

2015

Headquarters

Chicago, Illinois

Growth & Insights
Headcount

6 month growth

7%

1 year growth

27%

2 year growth

51%
Locations
Chicago, IL, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
CategoriesNew
Lab & Research
Life Sciences
Medical Research
Requirements
  • Ph.D. in oncology, molecular systems biology, or a related field
  • 2+ years of industry or post-doctoral experience
  • Experience with 3D human tissue models
  • Experience working with next-generation sequencing data
  • Experience coordinating complex experimental workflows across multidisciplinary teams
Responsibilities
  • Work in a collaborative, interdisciplinary team of scientists employing gene-editing approaches to perturb cellular pathways with the aim of identifying therapeutic targets
  • Design and execute high-throughput gene-editing, imaging and protein detection workflows
  • Work with automated liquid and plate platforms at all stages of development
  • Execute bulk and scSequencing studies end-to-end
  • Develop analysis pipelines to process and visualize large high-throughput data sets
  • Generate summary reports of screening results and molecular data for customer deliverables